FUGE-Funksjonell genomforskn.i Norg
Proteome analysis of acute myelogenous leukemia (AML). Molecular mechanisms of cell death regul. in AML rel. to cytogenetics and prognosis.
The malignant hematological disease acute myelogenous leukemia (AML) has an overall long-term survival of 50%, with far worse outcomes in patients over 60 years of age. AML material >90% pure will be collected from patients, before chemotherapy, during c hemotherapy and at disease relapse. Kryo...